Drug Profile


Alternative Names: HIV DNA vaccine - Vaccine Research Center; Plasmid DNA HIV vaccine - Vaccine Research Center; VRC HIVDNA016 00 VP

Latest Information Update: 30 Jun 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator National Institute of Allergy and Infectious Diseases; Vaccine Research Center
  • Developer National Institute of Allergy and Infectious Diseases
  • Class AIDS vaccines; DNA vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II HIV infections

Most Recent Events

  • 01 Jun 2016 NIAID completes a phase Ib trial in HIV infections (Prevention, In volunteers) in USA (NCT01054872)
  • 07 Sep 2015 No recent reports on development identified - Phase-II for HIV infections (Prevention) in Africa, Brazil and Jamaica (IM)
  • 21 Jul 2015 VRC-HIVDNA016-00-VP is still in phase II trials for HIV infections (Prevention) in USA (NCT00865566)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top